Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 221 articles: HTML format

Single Articles

September 2020
1. LIN CC, Chen TH, Wu YC, Fang CY, et al
   Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer.
   Ann Surg Oncol. 2020 Sep 1. pii: 10.1245/s10434-020-08914.
   PubMed     Abstract available
   
   
   August 2020
2. FONG AJ, Lafaro K, Ituarte PHG, Fong Y, et al
   Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.
   Ann Surg Oncol. 2020 Aug 25. pii: 10.1245/s10434-020-09049.
   PubMed     Abstract available
   
   
   
3. KIM HS, Kim NK
   ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2020 Aug 19. pii: 10.1245/s10434-020-09047.
   PubMed    
   
   
   
4. XIE H, Kim RD
   ASO Author Reflections: Clinical Utility of Circulating Tumor DNA Analysis in Colorectal Cancer: Current Status.
   Ann Surg Oncol. 2020 Aug 18. pii: 10.1245/s10434-020-09034.
   PubMed    
   
   
   
5. XIE H, Kim RD
   The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer.
   Ann Surg Oncol. 2020 Aug 9. pii: 10.1245/s10434-020-09002.
   PubMed     Abstract available
   
   
   
6. NORO T
   ASO Author Reflections: Prognostic Impact of Budding Grade on Patients with Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
   Ann Surg Oncol. 2020 Aug 7. pii: 10.1245/s10434-020-08792.
   PubMed    
   
   
   
7. ALLAIX ME, Rebecchi F, Fichera A
   ASO Author Reflections: Minimally Invasive Surgery for Colorectal Cancer: Where Do We Stand?
   Ann Surg Oncol. 2020 Aug 5. pii: 10.1245/s10434-020-08849.
   PubMed    
   
   
   July 2020
8. SASO K, Miyoshi N, Fujino S, Sasaki M, et al
   Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.
   Ann Surg Oncol. 2020 Jul 30. pii: 10.1245/s10434-020-08729.
   PubMed     Abstract available
   
   
   
9. ALLAIX ME, Rebecchi F, Fichera A
   The Landmark Series: Minimally Invasive (Laparoscopic and Robotic) Colorectal Cancer Surgery.
   Ann Surg Oncol. 2020 Jul 9. pii: 10.1245/s10434-020-08833.
   PubMed     Abstract available
   
   
   
10. AKIYAMA T, Miyamoto Y, Imai K, Yamashita Y, et al
    Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2020 Jul 9. pii: 10.1245/s10434-020-08828.
    PubMed     Abstract available
    
    
    
11. MAKAR GS, Makar M, Obinero C, Davis W, et al
    Refusal of Cancer-Directed Surgery in Patients with Colon Cancer: Risk Factors of Refusal and Survival Data.
    Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08783.
    PubMed     Abstract available
    
    
    
12. SHERMAN SK, Chan CHF
    ASO Author Reflections: Mismatch Repair and Survival in Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2020 Jul 6. pii: 10.1245/s10434-020-08803.
    PubMed    
    
    
    
13. CHOI AH, Senthil M
    ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters.
    Ann Surg Oncol. 2020 Jul 6. pii: 10.1245/s10434-020-08773.
    PubMed    
    
    
    
14. MAKAR GS, Davis W
    ASO Author Reflections: Which Patients with Colon Cancer Refuse Recommended Surgery?
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08798.
    PubMed    
    
    
    June 2020
15. YOKOBORI T
    Editorial Comment on: DPP9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2020 Jun 22. pii: 10.1245/s10434-020-08746.
    PubMed    
    
    
    
16. CHOI AH, Farzaneh C, Kejriwal N, Calidas A, et al
    Rate of Peritoneal Carcinomatosis in Resected Stage II and III Colon Cancer.
    Ann Surg Oncol. 2020 Jun 14. pii: 10.1245/s10434-020-08689.
    PubMed     Abstract available
    
    
    
17. NORO T, Nishikawa M, Hoshikawa M, Einama T, et al
    Prognostic Impact of Budding Grade in Patients With Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Ann Surg Oncol. 2020 Jun 2. pii: 10.1245/s10434-020-08684.
    PubMed     Abstract available
    
    
    May 2020
18. KRATZ JD, LoConte NK
    Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2020 May 22. pii: 10.1245/s10434-020-08629.
    PubMed    
    
    
    April 2020
19. SHINTO E, Yoshida Y, Kajiwara Y, Okamoto K, et al
    Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon Cancer.
    Ann Surg Oncol. 2020 Apr 23. pii: 10.1245/s10434-020-08498.
    PubMed     Abstract available
    
    
    
20. PARK JH, Fuglestad AJ, Kostner AH, Oliwa A, et al
    Systemic Inflammation and Outcome in 2295 Patients with Stage I-III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group.
    Ann Surg Oncol. 2020 Apr 4. pii: 10.1245/s10434-020-08268.
    PubMed     Abstract available
    
    
    
21. PAMEIJER CR
    Comment on "Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery".
    Ann Surg Oncol. 2020;27:975-977.
    PubMed    
    
    
    
22. ENGBERSEN MP, Aalbers AGJ, Van't Sant-Jansen I, Velsing JDR, et al
    Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer.
    Ann Surg Oncol. 2020 Apr 1. pii: 10.1245/s10434-020-08416.
    PubMed     Abstract available
    
    
    March 2020
23. BEOM SH, Shin SJ, Kim CG, Kim JH, et al
    Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection.
    Ann Surg Oncol. 2020 Mar 16. pii: 10.1245/s10434-020-08256.
    PubMed     Abstract available
    
    
    
24. MODEST DP, Heinemann V, Folprecht G, Denecke T, et al
    Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
    Ann Surg Oncol. 2020 Mar 14. pii: 10.1245/s10434-020-08219.
    PubMed     Abstract available
    
    
    
25. VELD JV, Wisselink DD, Amelung FJ, Consten ECJ, et al
    Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08327.
    PubMed     Abstract available
    
    
    February 2020
26. ZAFAR SN, Hu CY, Snyder RA, Cuddy A, et al
    Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study.
    Ann Surg Oncol. 2020 Feb 20. pii: 10.1245/s10434-020-08238.
    PubMed     Abstract available
    
    
    
27. IMAIZUMI K, Nishizawa Y, Ikeda K, Tsukada Y, et al
    Prognostic Impact of Curative Resection for Peritoneal Recurrence of Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 12. pii: 10.1245/s10434-020-08242.
    PubMed     Abstract available
    
    
    
28. BOEDING JRE, Schreinemakers JMJ
    ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
    PubMed    
    
    
    January 2020
29. CHARLTON M, Kahl A, Gao X, Schroeder M, et al
    Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to b
    Ann Surg Oncol. 2020 Jan 2. pii: 10.1245/s10434-019-08150.
    PubMed    
    
    
    
30. OSTERMAN E, Mezheyeuski A, Sjoblom T, Glimelius B, et al
    Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.
    Ann Surg Oncol. 2020 Jan 1. pii: 10.1245/s10434-019-08148.
    PubMed     Abstract available
    
    
    
31. BARATTI D, Kusamura S, Azmi N, Guaglio M, et al
    Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Ann Surg Oncol. 2020;27:98-106.
    PubMed     Abstract available
    
    
    
32. NARAYAN RR, Harris JW, Chou JF, Gonen M, et al
    Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2020;27:188-195.
    PubMed     Abstract available
    
    
    
33. ZAIDI MY, Lee RM, Gamboa AC, Speegle S, et al
    Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:156-164.
    PubMed     Abstract available
    
    
    
34. GRAF W, Cashin PH, Ghanipour L, Enblad M, et al
    Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.
    Ann Surg Oncol. 2020;27:293-300.
    PubMed     Abstract available
    
    
    
35. GAMBOA AC, Zaidi MY, Lee RM, Speegle S, et al
    Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:134-146.
    PubMed     Abstract available
    
    
    
36. ELLIS RJ, Schlick CJR, Yang AD, Barber EL, et al
    Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States.
    Ann Surg Oncol. 2020;27:214-221.
    PubMed     Abstract available
    
    
    December 2019
37. OSTERMAN E, Glimelius B
    ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
    Ann Surg Oncol. 2019 Dec 28. pii: 10.1245/s10434-019-08149.
    PubMed    
    
    
    
38. SHULMAN LN
    Dr Charlton et al., Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regio
    Ann Surg Oncol. 2019 Dec 19. pii: 10.1245/s10434-019-08152.
    PubMed    
    
    
    
39. KWAAN MR
    Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data.
    Ann Surg Oncol. 2019 Dec 18. pii: 10.1245/s10434-019-08151.
    PubMed    
    
    
    
40. BOEDING JRE, Ramphal W, Crolla RMPH, Gobardhan PD, et al
    Differences in Metastatic Pattern in Patients Presenting With or Without Obstructing Colorectal Cancer: A Retrospective Observational Study of 2595 Patients.
    Ann Surg Oncol. 2019 Dec 10. pii: 10.1245/s10434-019-08119.
    PubMed     Abstract available
    
    
    
41. BROUWER NPM, van der Kruijssen DEW, Hugen N, de Hingh IHJT, et al
    The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
    Ann Surg Oncol. 2019 Dec 2. pii: 10.1245/s10434-019-08100.
    PubMed     Abstract available
    
    
    
42. KURBATOV V, Khan SA
    Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST).
    Ann Surg Oncol. 2019 Dec 1. pii: 10.1245/s10434-019-08051.
    PubMed    
    
    
    November 2019
43. BROMAN KK, Parikh AA
    ASO Author Reflections: Location of Primary Colorectal Cancer and Risk of Second Primary Malignancy.
    Ann Surg Oncol. 2019 Nov 15. pii: 10.1245/s10434-019-07860.
    PubMed    
    
    
    
44. ITABASHI M, Yamamoto H, Tomita N, Inomata M, et al
    Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter Study.
    Ann Surg Oncol. 2019 Nov 13. pii: 10.1245/s10434-019-07971.
    PubMed     Abstract available
    
    
    
45. SUZUKI S, Akiyoshi T, Oba K, Otsuka F, et al
    Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-07904.
    PubMed     Abstract available
    
    
    
46. ZHANG Q, Peng J, Ye M, Weng W, et al
    KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08065.
    PubMed     Abstract available
    
    
    
47. WEGNER RE, Abel S, Monga D, Raj M, et al
    Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08042.
    PubMed     Abstract available
    
    
    
48. SUZUKI S, Akiyoshi T
    ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08019.
    PubMed    
    
    
    
49. TURPIN A, Hebbar M
    ASO Author Reflections: Fong's Score in the Era of Modern Strategies for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08059.
    PubMed    
    
    
    
50. WATSON MM, Kanani A, Lea D, Khajavi RB, et al
    Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Ann Surg Oncol. 2019 Nov 4. pii: 10.1245/s10434-019-08048.
    PubMed     Abstract available
    
    
    October 2019
51. MARIANI A, Goere D
    ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
    Ann Surg Oncol. 2019 Oct 30. pii: 10.1245/s10434-019-07829.
    PubMed    
    
    
    
52. MCSORLEY ST, Tham A, Dolan RD, Steele CW, et al
    Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2019 Oct 29. pii: 10.1245/s10434-019-07984.
    PubMed     Abstract available
    
    
    
53. ARRAZUBI V
    ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-08005.
    PubMed    
    
    
    
54. MAKHLOUFI S, Turpin A, El Amrani M, Andre T, et al
    Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.
    Ann Surg Oncol. 2019 Oct 22. pii: 10.1245/s10434-019-07976.
    PubMed     Abstract available
    
    
    
55. VAN WYK HC, Roseweir A, Alexander P, Park JH, et al
    The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07931.
    PubMed     Abstract available
    
    
    
56. KOTHA NV, Kelly KJ
    ASO Author Reflections: Clinical Significance of Primary Tumor Side in Peritoneal Metastatic Colon Cancer.
    Ann Surg Oncol. 2019 Oct 10. pii: 10.1245/s10434-019-07916.
    PubMed    
    
    
    
57. WANG YY, Liu ZZ, Xu D, Liu M, et al
    Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2019;26:3682-3692.
    PubMed     Abstract available
    
    
    
58. RIBI K, Marti WR, Bernhard J, Grieder F, et al
    Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04).
    Ann Surg Oncol. 2019;26:3568-3576.
    PubMed     Abstract available
    
    
    
59. JEDDOU H, Tzedakis S, Sulpice L, Boudjema K, et al
    Resection of the Dorsal Sector of the Liver: The Anterior Transhepatic Approach.
    Ann Surg Oncol. 2019;26:3681.
    PubMed     Abstract available
    
    
    September 2019
60. YOKOTA K, Tanaka Y, Harada H, Kaida T, et al
    WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Ann Surg Oncol. 2019 Sep 23. pii: 10.1245/s10434-019-07780.
    PubMed     Abstract available
    
    
    
61. IWAMOTO K, Takahashi H, Fujii M, Haraguchi N, et al
    Correction to: Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2019 Sep 17. pii: 10.1245/s10434-019-07839.
    PubMed     Abstract available
    
    
    
62. IWAMOTO K, Takahashi H, Fujii M, Haraguchi N, et al
    Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2019 Sep 6. pii: 10.1245/s10434-019-07794.
    PubMed     Abstract available
    
    
    
63. KARAGKOUNIS G, Liska D
    Bridging the Gap: Making Sense of the Diverging Evidence for Self-Expandable Metallic Stents in Malignant Colonic Obstructions.
    Ann Surg Oncol. 2019;26:2657-2659.
    PubMed    
    
    
    
64. STROMBOM P, Widmar M, Keskin M, Gennarelli RL, et al
    Assessment of the Value of Comorbidity Indices for Risk Adjustment in Colorectal Surgery Patients.
    Ann Surg Oncol. 2019;26:2797-2804.
    PubMed     Abstract available
    
    
    
65. HOPPENER DJ, Nierop PMH, van Amerongen MJ, Olthof PB, et al
    The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Ann Surg Oncol. 2019;26:2812-2820.
    PubMed     Abstract available
    
    
    
66. YANG SY, Park YY, Han YD, Cho MS, et al
    Oncologic Outcomes of Self-Expandable Metallic Stent as a Bridge to Surgery and Safety and Feasibility of Minimally Invasive Surgery for Acute Malignant Colonic Obstruction.
    Ann Surg Oncol. 2019;26:2787-2796.
    PubMed     Abstract available
    
    
    August 2019
67. SHINDOH J, Kobayashi Y, Kinowaki K, Mise Y, et al
    Dynamic Changes in Normal Liver Parenchymal Volume During Chemotherapy for Colorectal Cancer: Liver Atrophy as an Alternate Marker of Chemotherapy-Associated Liver Injury.
    Ann Surg Oncol. 2019 Aug 22. pii: 10.1245/s10434-019-07740.
    PubMed     Abstract available
    
    
    
68. YOSHIDA T, Shida D
    ASO Author Reflections: Partial versus Total Cystectomy in Bladder-Involving Colorectal Cancer.
    Ann Surg Oncol. 2019 Aug 9. pii: 10.1245/s10434-019-07716.
    PubMed    
    
    
    
69. ARJONA-SANCHEZ A, Rodriguez-Ortiz L, Baratti D, Schneider MA, et al
    RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Ann Surg Oncol. 2019;26:2595-2604.
    PubMed     Abstract available
    
    
    
70. YANG Y, Malakorn S, Maldonado K, Bednarski BK, et al
    The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon.
    Ann Surg Oncol. 2019;26:2514-2515.
    PubMed     Abstract available
    
    
    
71. HALVERSON AL, Morris AM, Cleary RK, Chang GJ, et al
    For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?
    Ann Surg Oncol. 2019;26:2497-2506.
    PubMed     Abstract available
    
    
    
72. ARJONA-SANCHEZ A, Rodriguez-Ortiz L
    ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC.
    Ann Surg Oncol. 2019;26:2605-2606.
    PubMed    
    
    
    
73. KONISHI T, Shinozaki E, Murofushi K, Taguchi S, et al
    Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
    Ann Surg Oncol. 2019;26:2507-2513.
    PubMed     Abstract available
    
    
    
74. MATSUDA T, Hasegawa H, Yamashita K, Takase N, et al
    Laparoscopic Complete Mesocolic Excision for Double Flexural Colon Cancers.
    Ann Surg Oncol. 2019;26:2516.
    PubMed     Abstract available
    
    
    July 2019
75. SHIDA D
    ASO Author Reflections: Prognostic Impact of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07666.
    PubMed    
    
    
    
76. YOMODA T
    ASO Author Reflections: Analysis of PD-L1 Expression and Immunoscore in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jul 22. pii: 10.1245/s10434-019-07363.
    PubMed    
    
    
    
77. ROXBURGH CSD, Strombom P, Lynn P, Gonen M, et al
    Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:2019-2027.
    PubMed     Abstract available
    
    
    
78. FERNANDEZ LM, Perez RO
    Longer Intervals from Neoadjuvant Therapy to Rectal Cancer Surgery: The Clock is Ticking....
    Ann Surg Oncol. 2019;26:1957-1958.
    PubMed    
    
    
    
79. FIELDS AC, McCarty JC, Lu P, Vierra BM, et al
    Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
    Ann Surg Oncol. 2019;26:2028-2036.
    PubMed     Abstract available
    
    
    
80. HENTZEN JEKR, Rovers KP, Kuipers H, van der Plas WY, et al
    Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Ann Surg Oncol. 2019;26:2210-2221.
    PubMed     Abstract available
    
    
    June 2019
81. LAZARUS J, Oneka MD, Barua S, Maj T, et al
    Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells.
    Ann Surg Oncol. 2019 Jun 27. pii: 10.1245/s10434-019-07508.
    PubMed     Abstract available
    
    
    
82. ARRAZUBI V, Mata E, Antelo ML, Tarifa A, et al
    Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07503.
    PubMed     Abstract available
    
    
    
83. BRUZZI M, Auclin E, Lo Dico R, Voron T, et al
    Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07513.
    PubMed     Abstract available
    
    
    
84. TANAKA T, Yamashita K
    ASO Author Reflections: ASCL2, a Marker of Dynamic Colon Stem Cell, Involved in Wnt Pathway Activation Reflects Anti-cancer Drug Resistance in Primary Colorectal Cancer.
    Ann Surg Oncol. 2019 Jun 13. pii: 10.1245/s10434-019-07469.
    PubMed    
    
    
    
85. ZHOU X, Yi Y, Liu Z, Cao W, et al
    Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:1676-1684.
    PubMed     Abstract available
    
    
    May 2019
86. CHOUDRY HA, Bednar F, Shuai Y, Jones HL, et al
    Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
    Ann Surg Oncol. 2019;26:1445-1453.
    PubMed     Abstract available
    
    
    
87. MARIANI A, Gelli M, Sourrouille I, Benhaim L, et al
    Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2019;26:1437-1444.
    PubMed     Abstract available
    
    
    
88. LEWIS GD, Haque W, Butler EB, Teh BS, et al
    Survival Outcomes and Patterns of Management for Anal Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1351-1357.
    PubMed     Abstract available
    
    
    April 2019
89. PEREYRA D, Starlinger P
    ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection.
    Ann Surg Oncol. 2019 Apr 29. pii: 10.1245/s10434-019-07395.
    PubMed    
    
    
    
90. KOTHA NV, Baumgartner JM, Veerapong J, Cloyd JM, et al
    Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07373.
    PubMed     Abstract available
    
    
    
91. BROMAN KK, Bailey CE, Parikh AA
    Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy.
    Ann Surg Oncol. 2019 Apr 4. pii: 10.1245/s10434-019-07326.
    PubMed     Abstract available
    
    
    
92. BERGER Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al
    Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2019;26:1103-1109.
    PubMed     Abstract available
    
    
    
93. HAGEMANS JAW, Rothbarth J, van Bogerijen GHW, van Meerten E, et al
    Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1134-1141.
    PubMed     Abstract available
    
    
    
94. FIELDS AC, Lu P, Vierra BM, Hu F, et al
    Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
    Ann Surg Oncol. 2019;26:1127-1133.
    PubMed     Abstract available
    
    
    March 2019
95. SHULMAN LN, Browner AE, Palis BE, Mallin K, et al
    Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Rese
    Ann Surg Oncol. 2019 Mar 29. pii: 10.1245/s10434-019-07323.
    PubMed     Abstract available
    
    
    
96. HUANG SH, Tsai WS, You JF, Hung HY, et al
    Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Ann Surg Oncol. 2019 Mar 26. pii: 10.1245/s10434-019-07184.
    PubMed     Abstract available
    
    
    
97. KAMATH SD, Khorana AA
    Does Sidedness Matter in Unresectable Colorectal Cancer?
    Ann Surg Oncol. 2019 Mar 18. pii: 10.1245/s10434-019-07315.
    PubMed    
    
    
    
98. YOSHIDA T, Shida D, Taniguchi H, Tsukamoto S, et al
    Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion.
    Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07276.
    PubMed     Abstract available
    
    
    
99. VELD JV, Amelung FJ, van Hooft JE, Tanis PJ, et al
    Letter to the Editor Regarding 'What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical
    Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07279.
    PubMed    
    
    
    
100. MEGE D, Sabbagh C, Manceau G, Karoui M, et al
     Response to Dr. Veld et al. Regarding the Manuscript Titled "What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score An
     Ann Surg Oncol. 2019 Mar 6. pii: 10.1245/s10434-019-07281.
     PubMed    
     
     
     
101. SOTIRCHOS VS, Fujisawa S, Vakiani E, Solomon SB, et al
     Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.
     Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-018-07133.
     PubMed     Abstract available
     
     
     
102. PEREYRA D, Rumpf B, Ammann M, Perrodin SF, et al
     The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2019;26:791-799.
     PubMed     Abstract available
     
     
     
103. VAN HOUDT WJ, Wei IH, Kuk D, Qin LX, et al
     Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
     Ann Surg Oncol. 2019;26:765-771.
     PubMed     Abstract available
     
     
     
104. SUN W, Dou R, Chen J, Lai S, et al
     Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial.
     Ann Surg Oncol. 2019;26:746-755.
     PubMed     Abstract available
     
     
     February 2019
105. KELLY KJ, Alsayadnasser M, Vaida F, Veerapong J, et al
     Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
     Ann Surg Oncol. 2019 Feb 27. pii: 10.1245/s10434-019-07255.
     PubMed     Abstract available
     
     
     
106. HA GW, Kim JH, Lee MR
     Oncologic Effects of Primary Tumor-Sidedness on Patients with Stages 1-3 Colon Cancer: A Meta-Analysis.
     Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07164.
     PubMed     Abstract available
     
     
     
107. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
     Correction to: Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
     Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07267.
     PubMed     Abstract available
     
     
     
108. SHIDA D, Tanabe T, Boku N, Takashima A, et al
     Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
     Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07209.
     PubMed     Abstract available
     
     
     
109. FEFERMAN Y, Solomon D, Bhagwandin S, Kim J, et al
     Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
     Ann Surg Oncol. 2019;26:482-489.
     PubMed     Abstract available
     
     
     
110. DETERING R, Borstlap WAA, Broeders L, Hermus L, et al
     Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
     Ann Surg Oncol. 2019;26:437-448.
     PubMed     Abstract available
     
     
     
111. PALTER VN, Baker NA, Pollett A, Daly C, et al
     Learning by Example: An International Perspective on Reflex-Testing for Lynch Syndrome.
     Ann Surg Oncol. 2019;26:425-436.
     PubMed     Abstract available
     
     
     January 2019
112. NARAYAN RR, Goldman DA, Gonen M, Reichel J, et al
     Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07201.
     PubMed     Abstract available
     
     
     
113. TANAKA T, Kojima K, Yokota K, Tanaka Y, et al
     Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
     Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07172.
     PubMed     Abstract available
     
     
     
114. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
     Correction to: The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
     Ann Surg Oncol. 2019 Jan 29. pii: 10.1245/s10434-019-07208.
     PubMed     Abstract available
     
     
     
115. HAMILTON TD, MacNeill AJ, Lim H, Hunink MGM, et al
     Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2019 Jan 28. pii: 10.1245/s10434-018-07111.
     PubMed     Abstract available
     
     
     
116. LEE SY, Kim DW, Kang SI, Ihn MH, et al
     Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer.
     Ann Surg Oncol. 2019 Jan 25. pii: 10.1245/s10434-019-07179.
     PubMed     Abstract available
     
     
     
117. JACOBSON R, Sherman SK, Dahdaleh F, Turaga KK, et al
     Correction to: Peritoneal Metastases in Colorectal Cancer.
     Ann Surg Oncol. 2019 Jan 16. pii: 10.1245/s10434-019-07173.
     PubMed     Abstract available
     
     
     
118. SOLOMON D, DeNicola NL, Feferman Y, Bekhor E, et al
     More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
     Ann Surg Oncol. 2019 Jan 14. pii: 10.1245/s10434-018-07087.
     PubMed     Abstract available
     
     
     
119. MEGE D, Sabbagh C, Manceau G, Bridoux V, et al
     What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort
     Ann Surg Oncol. 2019 Jan 8. pii: 10.1245/s10434-018-07139.
     PubMed     Abstract available
     
     
     
120. SLUITER NR, Tuynman JB
     ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases.
     Ann Surg Oncol. 2019;26:165-166.
     PubMed    
     
     
     
121. SLUITER NR, Vlek SL, Wijsmuller AR, Brandsma HT, et al
     Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques.
     Ann Surg Oncol. 2019;26:156-164.
     PubMed     Abstract available
     
     
     
122. MACHADO MA, Surjan RC, Basseres T, Makdissi F, et al
     Robotic Repeat Right Hepatectomy for Recurrent Colorectal Liver Metastasis.
     Ann Surg Oncol. 2019;26:292-295.
     PubMed     Abstract available
     
     
     
123. LEE AJ, Loyer EM, Kang HC, Aloia TA, et al
     Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2019;26:275-281.
     PubMed     Abstract available
     
     
     
124. DUCHALAIS E, Larson DW, Machairas N, Mathis KL, et al
     Outcomes of Early Removal of Urinary Catheter Following Rectal Resection for Cancer.
     Ann Surg Oncol. 2019;26:79-85.
     PubMed     Abstract available
     
     
     December 2018
125. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
     The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
     Ann Surg Oncol. 2018 Dec 19. pii: 10.1245/s10434-018-07110.
     PubMed     Abstract available
     
     
     
126. FLAHERTY DC, Bilchik AJ
     ASO Author Reflections: Can the Association Between Obesity and Colorectal Cancer Be Explained by an Unfavorable Tumor Immune Microenvironment?
     Ann Surg Oncol. 2018 Dec 6. pii: 10.1245/s10434-018-7011.
     PubMed    
     
     
     
127. CHOUDRY MHA, Shuai Y, Jones HL, Pai RK, et al
     Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.
     Ann Surg Oncol. 2018;25:3950-3959.
     PubMed     Abstract available
     
     
     
128. KIM WR, Han YD, Min BS
     C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
     Ann Surg Oncol. 2018;25:3898-3905.
     PubMed     Abstract available
     
     
     November 2018
129. OSHI M, Margonis GA, Sawada Y, Andreatos N, et al
     Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
     Ann Surg Oncol. 2018 Nov 27. pii: 10.1245/s10434-018-6830.
     PubMed     Abstract available
     
     
     
130. PASSOT G, Vauthey JN, Chun YS
     ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2018 Nov 12. pii: 10.1245/s10434-018-7020.
     PubMed    
     
     
     
131. CLEARY RK, Morris AM, Chang GJ, Halverson AL, et al
     Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?
     Ann Surg Oncol. 2018;25:3587-3595.
     PubMed     Abstract available
     
     
     
132. ROUANET P, Bertrand MM, Jarlier M, Mourregot A, et al
     Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives.
     Ann Surg Oncol. 2018;25:3572-3579.
     PubMed     Abstract available
     
     
     October 2018
133. SOUWER ETD, Hultink D, Bastiaannet E, Hamaker ME, et al
     The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer.
     Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6867.
     PubMed     Abstract available
     
     
     
134. CREASY JM, D'Angelica MI
     ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
     Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6918.
     PubMed    
     
     
     
135. YOKOI K, Harada H, Yokota K, Ishii S, et al
     Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
     Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6865.
     PubMed     Abstract available
     
     
     
136. PINAR I, Fransgaard T, Thygesen LC, Gogenur I, et al
     Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer.
     Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6862.
     PubMed     Abstract available
     
     
     
137. SHINTO E, Hida JI, Ike H, Kobayashi H, et al
     A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.
     Ann Surg Oncol. 2018 Oct 1. pii: 10.1245/s10434-018-6786.
     PubMed     Abstract available
     
     
     
138. ACUNA SA, Chesney TR, Amarasekera ST, Baxter NN, et al
     Defining Non-inferiority Margins for Quality of Surgical Resection for Rectal Cancer: A Delphi Consensus Study.
     Ann Surg Oncol. 2018;25:3171-3178.
     PubMed     Abstract available
     
     
     September 2018
139. WEERINK LBM, Gant CM, van Leeuwen BL, de Bock GH, et al
     Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.
     Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6766.
     PubMed     Abstract available
     
     
     
140. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
     Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
     Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6752.
     PubMed     Abstract available
     
     
     
141. FIELDS AC, Goldberg J, Senturk J, Saadat LV, et al
     Contemporary Surgical Management and Outcomes for Anal Melanoma: A National Cancer Database Analysis.
     Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6769.
     PubMed     Abstract available
     
     
     
142. ANGKA L, Martel AB, Kilgour M, Jeong A, et al
     Natural Killer Cell IFNgamma Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
     Ann Surg Oncol. 2018 Sep 5. pii: 10.1245/s10434-018-6691.
     PubMed     Abstract available
     
     
     
143. ASARE EA, Vreeland TJ, Feig BW
     Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach.
     Ann Surg Oncol. 2018;25:2641.
     PubMed     Abstract available
     
     
     August 2018
144. MIRKIN KA, Kulaylat AS, Hollenbeak CS, Messaris E, et al
     Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
     Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6661.
     PubMed     Abstract available
     
     
     
145. LEE ZJ, Chia SL, Tan G, Soo KC, et al
     Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis.
     Ann Surg Oncol. 2018;25:2340-2346.
     PubMed     Abstract available
     
     
     
146. SLUITER NR, Rovers KP, Salhi Y, Vlek SL, et al
     Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
     Ann Surg Oncol. 2018;25:2347-2356.
     PubMed     Abstract available
     
     
     
147. BECERRA AZ, Wexner SD, Dietz DW, Xu Z, et al
     Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
     Ann Surg Oncol. 2018;25:2332-2339.
     PubMed     Abstract available
     
     
     July 2018
148. LEE DW, Han SW, Kang JK, Bae JM, et al
     Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
     Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
     PubMed     Abstract available
     
     
     
149. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
     Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
     Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
     PubMed     Abstract available
     
     
     
150. HAGEMANS JAW, Blinde SE, Nuyttens JJ, Morshuis WG, et al
     Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
     Ann Surg Oncol. 2018;25:1970-1979.
     PubMed     Abstract available
     
     
     
151. VAN EDEN WJ, Elekonawo FMK, Starremans BJ, Kok NFM, et al
     Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
     Ann Surg Oncol. 2018;25:1992-2001.
     PubMed     Abstract available
     
     
     June 2018
152. HAMABE A, Park S, Morita S, Tanida T, et al
     Analysis of the Vascular Interrelationships Among the First Jejunal Vein, the Superior Mesenteric Artery, and the Middle Colic Artery.
     Ann Surg Oncol. 2018;25:1661-1667.
     PubMed     Abstract available
     
     
     
153. FIORENTINI G, Ratti F, Cipriani F, Catena M, et al
     Tips and Tricks for a Laparoscopic Approach to Paracaval Liver Segments.
     Ann Surg Oncol. 2018;25:1695-1698.
     PubMed     Abstract available
     
     
     
154. GOFFREDO P, Garancini M, Robinson TJ, Frakes J, et al
     A National-Level Validation of the New American Joint Committee on Cancer 8th Edition Subclassification of Stage IIA and B Anal Squamous Cell Cancer.
     Ann Surg Oncol. 2018;25:1654-1660.
     PubMed     Abstract available
     
     
     
155. VIGANO L, Darwish SS, Rimassa L, Cimino M, et al
     Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
     Ann Surg Oncol. 2018;25:1676-1685.
     PubMed     Abstract available
     
     
     May 2018
156. OKUNO M, Goumard C, Kopetz S, Vega EA, et al
     RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
     Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6517.
     PubMed     Abstract available
     
     
     
157. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
     Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
     Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
     PubMed     Abstract available
     
     
     
158. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
     Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
     Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
     PubMed     Abstract available
     
     
     
159. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
     Peritoneal Metastases in Colorectal Cancer.
     Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
     PubMed    
     
     
     
160. SPASOJEVIC M, Mariathasan AB, Goscinski M, Thorgersen EB, et al
     Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2018;25:1357-1365.
     PubMed     Abstract available
     
     
     
161. WASIF N, Etzioni D, Habermann EB, Mathur A, et al
     Racial and Socioeconomic Differences in the Use of High-Volume Commission on Cancer-Accredited Hospitals for Cancer Surgery in the United States.
     Ann Surg Oncol. 2018;25:1116-1125.
     PubMed     Abstract available
     
     
     April 2018
162. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
     Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
     Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
     PubMed     Abstract available
     
     
     
163. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
     High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
     Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
     PubMed     Abstract available
     
     
     
164. WEISER MR
     AJCC 8th Edition: Colorectal Cancer.
     Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
     PubMed    
     
     
     
165. ZHOU H, Ruan C, Wang Z, Hu Z, et al
     Laparoscopic-Assisted Modified Intersphincter Resection for Ultralow Rectal Cancer.
     Ann Surg Oncol. 2018;25:947-948.
     PubMed     Abstract available
     
     
     March 2018
166. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
     Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
     Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
     PubMed     Abstract available
     
     
     
167. SIMONEAU E, Vauthey JN
     Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
     Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
     PubMed    
     
     
     
168. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
     The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
     Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
     PubMed     Abstract available
     
     
     
169. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
     Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
     Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
     PubMed     Abstract available
     
     
     
170. ARSONIADIS EG, Fan Y, Jarosek S, Gaertner WB, et al
     Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer.
     Ann Surg Oncol. 2018;25:720-728.
     PubMed     Abstract available
     
     
     
171. BLOK RD, Musters GD, Borstlap WAA, Buskens CJ, et al
     Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
     Ann Surg Oncol. 2018;25:729-736.
     PubMed     Abstract available
     
     
     
172. STEWART CL, Gleisner A, Halpern A, Ibrahim-Zada I, et al
     Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.
     Ann Surg Oncol. 2018;25:655-659.
     PubMed     Abstract available
     
     
     February 2018
173. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
     Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
     Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
     PubMed     Abstract available
     
     
     
174. DHIR M, Zenati MS, Jones HL, Bartlett DL, et al
     Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
     Ann Surg Oncol. 2018;25:550-557.
     PubMed     Abstract available
     
     
     January 2018
175. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, et al
     Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
     Ann Surg Oncol. 2018;25:32-37.
     PubMed     Abstract available
     
     
     
176. PAQUETTE IM, Madoff RD, Sigurdson ER, Chang GJ, et al
     Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer.
     Ann Surg Oncol. 2018;25:38-45.
     PubMed     Abstract available
     
     
     
177. HUPKENS BJP, Maas M, Martens MH, van der Sande ME, et al
     Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
     Ann Surg Oncol. 2018;25:197-203.
     PubMed     Abstract available
     
     
     December 2017
178. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
     Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
     Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
     PubMed     Abstract available
     
     
     November 2017
179. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
     The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
     Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
     PubMed     Abstract available
     
     
     
180. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
     The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
     Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
     PubMed     Abstract available
     
     
     October 2017
181. TIERNAN JP, Jayne DG
     Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
     Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
     PubMed    
     
     
     
182. OH BY, Park YA, Huh JW, Yun SH, et al
     Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
     Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
     PubMed     Abstract available
     
     
     
183. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
     Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
     Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
     PubMed    
     
     
     
184. WATANABE K, Salah S, Saito N
     Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
     Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
     PubMed    
     
     
     
185. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
     Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
     Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
     PubMed    
     
     
     
186. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
     Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
     Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
     PubMed     Abstract available
     
     
     
187. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
     Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
     Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
     PubMed     Abstract available
     
     
     
188. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
     Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
     Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
     PubMed     Abstract available
     
     
     September 2017
189. CLARKE CN, Lee MS, Wei W, Manyam G, et al
     Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
     Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
     PubMed     Abstract available
     
     
     
190. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
     External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
     Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
     PubMed     Abstract available
     
     
     August 2017
191. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
     Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
     Ann Surg Oncol. 2017;24:2095-2103.
     PubMed     Abstract available
     
     
     
192. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
     Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
     Ann Surg Oncol. 2017;24:2122-2128.
     PubMed     Abstract available
     
     
     
193. SCHNEIDER MA, Eshmuminov D, Lehmann K
     Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
     Ann Surg Oncol. 2017;24:2224-2232.
     PubMed     Abstract available
     
     
     
194. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
     Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
     Ann Surg Oncol. 2017;24:2113-2121.
     PubMed     Abstract available
     
     
     June 2017
195. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
     Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
     Ann Surg Oncol. 2017;24:1557-1568.
     PubMed     Abstract available
     
     
     
196. LIM TZ, Chan DKH, Tan KK
     Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
     Ann Surg Oncol. 2017;24:1618-1625.
     PubMed     Abstract available
     
     
     May 2017
197. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
     Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
     Ann Surg Oncol. 2017;24:1195-1201.
     PubMed     Abstract available
     
     
     
198. ACHARYA A, Markar SR, Matar M, Ni M, et al
     Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
     Ann Surg Oncol. 2017;24:1165-1173.
     PubMed     Abstract available
     
     
     
199. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
     Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
     Ann Surg Oncol. 2017;24:1304-1311.
     PubMed     Abstract available
     
     
     
200. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
     Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
     Ann Surg Oncol. 2017;24:1376-1377.
     PubMed     Abstract available
     
     
     
201. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
     The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
     Ann Surg Oncol. 2017;24:1295-1303.
     PubMed     Abstract available
     
     
     
202. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
     Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
     Ann Surg Oncol. 2017;24:1281-1288.
     PubMed     Abstract available
     
     
     April 2017
203. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
     Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
     Ann Surg Oncol. 2017;24:890-897.
     PubMed     Abstract available
     
     
     
204. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
     Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
     Ann Surg Oncol. 2017;24:875-883.
     PubMed     Abstract available
     
     
     
205. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
     Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
     Ann Surg Oncol. 2017;24:931-938.
     PubMed     Abstract available
     
     
     
206. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
     Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
     Ann Surg Oncol. 2017;24:990-997.
     PubMed     Abstract available
     
     
     
207. IHEMELANDU C
     Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
     Ann Surg Oncol. 2017;24:884-889.
     PubMed     Abstract available
     
     
     
208. IHEMELANDU C, Sugarbaker PH
     Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
     Ann Surg Oncol. 2017;24:898-905.
     PubMed     Abstract available
     
     
     
209. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
     Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
     Ann Surg Oncol. 2017;24:906-913.
     PubMed     Abstract available
     
     
     
210. VIGANO L, Lopci E, Costa G, Rodari M, et al
     Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
     Ann Surg Oncol. 2017;24:1029-1036.
     PubMed     Abstract available
     
     
     
211. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
     Total Laparoscopic Reversal ALPPS.
     Ann Surg Oncol. 2017;24:1048-1049.
     PubMed     Abstract available
     
     
     March 2017
212. WAITE K, Youssef H
     The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
     Ann Surg Oncol. 2017;24:705-720.
     PubMed     Abstract available
     
     
     
213. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
     Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2017;24:721-728.
     PubMed     Abstract available
     
     
     February 2017
214. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
     Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
     Ann Surg Oncol. 2017;24:311-318.
     PubMed     Abstract available
     
     
     
215. CHOI SH, Choi GH, Han DH, Kwon SW, et al
     Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
     Ann Surg Oncol. 2017;24:554-555.
     PubMed     Abstract available
     
     
     January 2017
216. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
     Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
     Ann Surg Oncol. 2017;24:251-256.
     PubMed     Abstract available
     
     
     
217. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
     Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
     Ann Surg Oncol. 2017;24:236-243.
     PubMed     Abstract available
     
     
     
218. BEPPU N, Kimura F, Aihara T, Doi H, et al
     Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
     Ann Surg Oncol. 2017;24:219-226.
     PubMed     Abstract available
     
     
     
219. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
     KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2017;24:264-271.
     PubMed     Abstract available
     
     
     
220. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
     Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
     Ann Surg Oncol. 2017;24:150-158.
     PubMed     Abstract available
     
     
     
221. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
     Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
     Ann Surg Oncol. 2017;24:23-30.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: